About Us

Contact Us

Race
Home About Us Product News Order Career Contact

                                                                                                            

           APIs&Intermediates Chemicals of Shanghai APIs Chemical Co., Ltd 

    

Product Indentification

Name:   Olaparib;AZD2218
Synonyms:   Azd2281;Azd 2281;Azd-2281;Olaparib;Ku-0059436;AZD2281(olaparib);Olaparib(AZD-2281);4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one;1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine;4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one Olaparib
CAS Registry Number:   763113-22-0
Molecular Formula:   C24H23FN4O3
Molecular Weight:    434.469
Molecular Structure:    

 

 

                    In stock! Bulk!

 

                   Purity:99%min

 

                   Storage: 4 deg C

 

                   Inquiry

 

 

Related PARP Pathway Inhibitors:

 

 

          BSI-201|160003-66-7

 

         AG-14699|459868-92-9   

 

         ABT888|912444-00-9  

 

         Olaparib|AZD-2281|CAS:763113-22-0  

  

          INO-1001|3544-24-9

 

          66611-37-8|BGP-15

          A-966492|934162-61-5


 

 

Related pages:


     Search Olaparib or AZD2218 in google
     Search CAS 763113-22-0  in google
     Search C24H23FN4O3  in google

 

 

Related info:

 

     Olaparib (AZD-2281) is a chemotherapeutic agent developed by KuDOS Pharmaceuticals and later by Astra Zeneca. It is an inhibitor of PARP, an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which includes many ovarian, breast and prostate cancers. Early (Phase I) trials have been promising, and it is now in Phase II trials, but is not clinically approved.

 

 

 

Home About Us Product News Order Career Contact
 Copyright @ 2010-2011 APIs All rights reserved
 

 

 

No_Right_Click

 

No_Right_Click